{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:45:07Z","timestamp":1768337107576,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jconrel.2014.03.038","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:33:17Z","timestamp":1396027997000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes"],"prefix":"10.1016","volume":"183","author":[{"given":"Rajesh","family":"Mukthavaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guixin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri","family":"Simberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.03.038_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","article-title":"Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice","volume":"83","author":"Daley","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0010","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.leu.2404558","article-title":"Rituximab in CD20 positive multiple myeloma","volume":"21","author":"Moreau","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0020","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-06-0066","article-title":"Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity","volume":"12","author":"van Meerten","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0025","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.2003.06.012","article-title":"Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance","volume":"21","author":"Bannerji","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1476-5586(03)80033-7","article-title":"ING-1(heMAb), a monoclonal antibody to epithelial cell adhesion molecule, inhibits tumor metastases in a murine cancer model","volume":"5","author":"Ruan","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0035","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/annonc\/mdr625","article-title":"Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer","volume":"23","author":"Schmidt","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.gt.3301758","article-title":"Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides","volume":"9","author":"Magnani","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425241003610633","article-title":"Drug delivery by red blood cells: vascular carriers designed by mother nature","volume":"7","author":"Muzykantov","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0050","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2005-11-012336","article-title":"Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis","volume":"108","author":"Zaitsev","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0055","first-page":"276","article-title":"Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide","volume":"128","author":"Muzykantov","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0014-5793(85)81154-6","article-title":"Targeting of enzyme immobilized on erythrocyte-membrane to collagen-coated surface","volume":"182","author":"Muzykantov","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-4165(86)90184-4","article-title":"Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot","volume":"884","author":"Muzykantov","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/adhm.201300084","article-title":"Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo","volume":"3","author":"Shi","year":"2014","journal-title":"Advanced healthcare materials"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0075","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.4049\/jimmunol.148.8.2462","article-title":"In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor","volume":"148","author":"Taylor","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0080","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/IAI.63.4.1329-1335.1995","article-title":"Complement-independent binding of microorganisms to primate erythrocytes in-vitro by cross-linked monoclonal-antibodies via complement receptor-1","volume":"63","author":"Powers","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0085","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1073\/pnas.88.8.3305","article-title":"Use of heteropolymeric monoclonal-antibodies to attach antigens to the C3b receptor of human erythrocytes \u2014 a potential therapeutic treatment","volume":"88","author":"Taylor","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/adhm.201300084","article-title":"Distearoyl anchor-painted erythrocytes with prolonged ligand retention and circulation properties in vivo","volume":"3","author":"Shi","year":"2014","journal-title":"Advanced healthcare materials"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0100","doi-asserted-by":"crossref","first-page":"R556","DOI":"10.1186\/bcr898","article-title":"Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance","volume":"6","author":"Choesmel","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.iy.07.040189.002011","article-title":"The leukocyte common antigen family","volume":"7","author":"Thomas","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.7541557","article-title":"In-vivo transfer of Gpi-linked complement restriction factors from erythrocytes to the endothelium","volume":"269","author":"Kooyman","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0115","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201010021","article-title":"Circulating tumor cells: approaches to isolation and characterization","volume":"192","author":"Yu","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2141.1998.00911.x","article-title":"Establishment and characterization of a mantle cell lymphoma cell line","volume":"102","author":"Jeon","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A biomimetic nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0145","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","article-title":"Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans","volume":"20","author":"Ra","year":"2011","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0150","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1572-0241.2005.41412.x","article-title":"Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients\u2014a pilot uncontrolled study","volume":"100","author":"Annese","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MPG.0b013e3180320667","article-title":"Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease","volume":"44","author":"Castro","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy\u2013refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0165","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1200\/JCO.2006.07.1100","article-title":"Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma","volume":"24","author":"Mackensen","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.coi.2009.03.002","article-title":"Adoptive cell therapy for the treatment of patients with metastatic melanoma","volume":"21","author":"Rosenberg","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0175","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V98.12.3383","article-title":"CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59","volume":"98","author":"Golay","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0180","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.347575","article-title":"Models for the specific adhesion of cells to cells","volume":"200","author":"Bell","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0190","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood.V95.6.2157","article-title":"Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice","volume":"95","author":"Terpstra","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0162-3109(99)00157-5","article-title":"Critical role of Kupffer cell CR3 (CD11b\/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan","volume":"46","author":"Yan","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jconrel.2014.03.038_bb0200","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1073\/pnas.0931428100","article-title":"Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs","volume":"100","author":"Torchilin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0205","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1074\/jbc.C300470200","article-title":"Engineered human IgG antibodies with longer serum half-lives in primates","volume":"279","author":"Hinton","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.03.038_bb0210","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/eji.1830180221","article-title":"The half-lives of serum immunoglobulins in adult mice","volume":"18","author":"Vieira","year":"1988","journal-title":"Eur. J. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:23:17Z","timestamp":1689078197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":42,"alternative-id":["S0168365914001837"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.038","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}